Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement

Apr

28

Today In Oncology

RAS Inhibitor Daraxonrasib in Metastatic Pancreatic Cancer

Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants

ACP Issues Controversial New Breast Cancer Screening Guidelines

Educational Disparities in Young-Onset Colorectal Cancer Mortality

Breast Cancer Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxicity

Advertisement

© 2026 HSP News Service, L.L.C.